A de novo Mutation (p.Gln277X) of Cyclin D2 is Responsible for a Child with Megalencephaly–Polymicrogyria–Polydactyly–Hydrocephalus Syndrome
DNA and Cell Biology · 2024
DOI: 10.1089/dna.2023.0391 ↗Kurz gefasst
Fallbericht in der Zeitschrift DNA and Cell Biology, 2024. Verfasst von Mei-Fang Zhao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Biology, School of Life Sciences, Central South University, Changsha, Republic of China. Hauptthemen laut MEDLINE: Cyclin D2, Megalencephaly, Polydactyly, Polymicrogyria. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 17 Literaturangaben.
Abstract (Originalsprache)
Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome (MPPH), a type of overgrowth syndrome, is characterized by progressive megalencephaly, cortical brain malformations, and distal limb anomalies. Previous studies have revealed that the overactivity of the phosphatidylinositol 3-kinase-Protein kinase B pathway and the increased cyclin D2 (CCND2) expression were the main factors contributing to this disease. Here, we present the case of a patient who exhibited megalencephaly, polymicrogyria, abnormal neuronal migration, and developmental delay. Serum tandem mass spectrometry and chromosome examination did not detect any metabolic abnormalities or copy number variants. However, whole-exome sequencing and Sanger sequencing revealed a de novo nonsense mutation (NM_001759.3: c.829C>T; p.Gln277X) in the CCND2 gene of the patient. Bioinformatics analysis predicted that this mutation may disrupt the structure and surface charge of the CCND2 protein. This disruption could potentially prevent polyubiquitination of CCND2, leading to its resistance against degradation. Consequently, this could drive cell division and growth by altering the activity of key cell cycle regulatory nodes, ultimately contributing to the development of MPPH. This study not only presents a new case of MPPH and expands the mutation spectrum of CCND2 but also enhances our understanding of the mechanisms connecting CCND2 with overgrowth syndromes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cell Biology, School of Life Sciences, Central South University, Changsha, Republic of China.
- Peking University China-Japan Friendship School of Clinical Medicine, Beijing, Republic of China.
- Departments of Reproductive Genetics, HeBei General Hospital, Shijiazhuang, Republic of China.
- Department of Anesthesiology, The Second Xiangya Hospital, Central South University, Changsha, Republic of China.
ORCID-Profile: Mei-Fang Zhao, Liang-Liang Fan
Zitieren
APA
Zhao, M. F., Zhang, S. L., Xiang, Y., Wang, Q., Cao, G. H., Zhang, P. P., Fan, L. L., Yu, R., & Li, Y. L. (2024). A de novo Mutation (p.Gln277X) of Cyclin D2 is Responsible for a Child with Megalencephaly–Polymicrogyria–Polydactyly–Hydrocephalus Syndrome. DNA and Cell Biology. https://doi.org/10.1089/dna.2023.0391
Vancouver
Zhao MF, Zhang SL, Xiang Y, Wang Q, Cao GH, Zhang PP, et al. A de novo Mutation (p.Gln277X) of Cyclin D2 is Responsible for a Child with Megalencephaly–Polymicrogyria–Polydactyly–Hydrocephalus Syndrome. DNA and Cell Biology. 2024. doi:10.1089/dna.2023.0391
BibTeX
@article{Zhao2024,
author = {Zhao, Mei-Fang and Zhang, Song-Lin and Xiang, YangZiYu and Wang, Qian and Cao, Gao-Hui and Zhang, Ping-Ping and Fan, Liang-Liang and Yu, Rong and Li, Ya-Li},
title = {A de novo Mutation (p.Gln277X) of Cyclin D2 is Responsible for a Child with Megalencephaly–Polymicrogyria–Polydactyly–Hydrocephalus Syndrome},
journal = {DNA and Cell Biology},
year = {2024},
doi = {10.1089/dna.2023.0391}
}
EUVIMED